Watchlist for April 2, 2008

See one of the recent 'Chart Reading' posts for some potential swing candidates. Also be sure to check my typical swing trade entry & exit rules.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to weak earnings/guidance/same store sales: DEEP -35.9% (co delays Q4 results; says if co is unable to obtain adequate additional or alternate financing, KPMG would be required to include going concern statement in financial statements), LOJN -22.4%, CHRD -16.0%, ONT -9.7%, LULU -6.2%, PAY -4.9%, BOBE -4.1%, CYTR -3.4%, LORL -2.7%, MON -1.4%, ATG -1.2%... Other news: PFB -23.3% (announces sale of DBS loans and preliminary credit-related information for Q4), ISTA -15.5% (announces results of clinical trial of Xibrom QD formulation; showed no statistically significant difference between the two formulations in achieving the secondary efficacy endpoints; also engages Cowen as Financial Advisor; co reaffirms FY08 rev guidance of $75-82 mln vs. $79.9 mln consensus), MEDX -15.5% (Pfizer announces discontinuation of Phase III clinical trial for patients with advanced melanoma, MEDX is PFE's partner for Tremelimumab), HNSN -4.1% (prices a 3 mln share common stock offering), NLY -2.3% (still checking), MOS -2.2% (down in sympathy with MON), AVY -1.4% (acquires DM Label Group), PFE -1.2% (announces discontinuation of Phase III clinical trial for patients with advanced melanoma)... Analyst downgrades: SCBT -7.1% (downgraded to Neutral from Buy at FTN Midwest), RAMR -6.8% (downgraded to Neutral at BofA), IRC -4.6% (downgraded to Underperform at Wachovia), CROX -2.3% (downgraded to Neutral at JPMorgan), EXPD -2.1% (downgraded to Neutral at UBS), CHU -1.8% (downgraded to Sell at Deutsche Bank), JBHT -1.3% (downgraded to Hold from Buy at Stifel).

Gapping Up

In reaction to strong earnings/guidance: BBY +6.7%, BLUD +5.9%, EXFO +4.9%, KMX +3.1%... Solar stocks showing strength with select co specific news out: CSUN +4.1%, TSL +3.8% (announced that the co has signed a long-term polysilicon supply agreement with a subsidiary of GCL Silicon Technology Holdings), EMKR +3.2%, SOLF +2.8%, EMKR +1.9% (receives $4.6 mln follow-on order for concentrator solar cell receiver assemblies from Concentration Solar la Mancha), STP +1.6% (to supply 4MW of modules to 'leading' Italian PV system developer Enerray), ESLR +1.0%... Select gold stocks showing strength with higher spot prices: GOLD +4.4%, IAG +4.3%, AU +1.7%, ABX +1.4%, GLD +1.3%, GFI +1.1%... Other news: TKO +19.8% (awarded exclusive 2-yr contract for hospitality energy efficiency program), SVA +14.9% (receives China State Food and Drug Administration approval for pandemic influenza H5N1 vaccine), CPST +7.0% (receives HEV bus order for $5 mln from DesignLine International), NCC +5.6% (in talks with KeyCorp - WSJ), CC +3.6% (up in sympathy with BBY), KKD +3.2% (seeks amendments to credit facilities), AMAT +2.6% (Cramer makes positive comments on MadMoney), FIC +2.2% (announces reengineering plan; expects to reduce cost structure by $100 mln, yield annual pre-tax savings of $35 mln and a Q2 charge of $7 mln), NOK +2.1% (still checking), CVTX +2.1% (announces Ranexa significantly reduces cardiac chest pain symptoms and recurrent ischemia in merlin-timi 36 patients with angina), BCE +2.0% (BCE deal will proceed as planned, adviser says - Globe and Mail), AER +2.0% (announced its subsidiary AeroTurbine entered into a ten year component lease agreement signed between British Airways and AeroTurbine), SIRT +1.8% (receives orphan drug designation from FDA for Resveratrol in Mitochondrial Disorder, MELAS syndrome), STM +1.5% (announces its Board has authorized the co repurchase up to 30 mln common shares), NBR +1.5% (Cramer makes positive comments on MadMoney)... Analyst upgrades: VRUS +6.1% (upgraded to Buy at UBS), VIP +3.0% (upgraded to Buy at tier 1 firm), HRS +1.3% (initiated with Buy at UBS).

Disclaimer & How I use this list